STOCK TITAN

Leidos Holdings Stock Price, News & Analysis

LDOS NYSE

Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.

Leidos Holdings, Inc. (NYSE: LDOS) delivers mission-critical technology and engineering solutions to defense, intelligence, and healthcare sectors. This news hub provides investors with essential updates about contract awards, strategic partnerships, and operational developments impacting this Fortune 500 leader.

Access timely press releases and analysis covering Leidos' defense modernization initiatives, cybersecurity advancements, and health IT innovations. Our curated collection helps stakeholders track progress in key areas like geospatial intelligence, digital transformation projects, and government contracting milestones.

Find updates on quarterly earnings, major Department of Defense contracts, and research breakthroughs in secure communications technology. All content is verified through primary sources to ensure accuracy for financial decision-making.

Bookmark this page for centralized access to Leidos' latest achievements in supporting national security infrastructure and advancing critical healthcare systems through technological innovation.

Rhea-AI Summary

Leidos Holdings has extended its offers for the exchange of various notes totaling $2.25 billion, including 2.950% Notes due 2023 and others, to expire on June 21, 2021. This extension is due to the announcement that June 18 will be a federal holiday. As of June 17, 2021, the company reported significant tendering amounts: 59.7% for the 2023 Notes and over 85% for the 2025 Notes. Other notes tendered include 70.1% for the 2030 Notes and 81.1% for the 2031 Notes. Citibank is the exchange agent for the offers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.32%
Tags
none
-
Rhea-AI Summary

Leidos (NYSE: LDOS) has secured a prime contract from the U.S. Army for commercial health services to military reserve forces, valued at $999 million if all options are exercised. This contract spans a one-year base period, with four additional one-year options. Leidos will collaborate with the Defense Health Agency to meet health requirements for service members before, during, and after deployment. Liz Porter, the Health Group president, emphasized the commitment to serving military reservists, while CEO Larry Schaefer stressed the dedication to innovation and customer service in healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.01%
Tags
none
-
Rhea-AI Summary

Leidos (NYSE: LDOS) announced its advancement into the final phase of the USSOCOM's Armed Overwatch aircraft prototype program alongside Paramount USA and Vertex. The team has been awarded $19.3 million for prototype demonstrations, focusing on the Bronco II aircraft, which boasts mission flexibility through its Interchangeable Multi-Mission System Bay. Leidos' team aims to showcase the Bronco II's capabilities for ISR, SCAR, and CAS missions. The program is critical for future military operational requirements, showcasing Leidos' ongoing commitment to innovative defense solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
none
Rhea-AI Summary

Leidos (NYSE: LDOS) announced its advancement to Phase III of the U.S. Special Operations Command's Armed Overwatch aircraft prototype program with its Bronco II aircraft. Partnering with Paramount Group USA and Vertex Aerospace, the Leidos team will demonstrate the aircraft's capabilities in a fly-off. Bronco II is designed for rapid deployment and modularity, allowing for diverse mission configurations. This contract signifies Leidos' commitment to providing advanced military solutions and supporting national defense.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
none
-
Rhea-AI Summary

Leidos (NYSE: LDOS), a leader in information technology and engineering, will participate in the Stifel 2021 Virtual Cross Sector Insight Conference on June 10, 2021, at 4:40 p.m. ET. Chris Cage, Corporate Controller and incoming CFO, will engage in a fireside chat during the event. Interested investors can access the live audio webcast on the Leidos Investor Relations website, with a replay available for 90 days post-event. Leidos reported revenues of approximately $12.30 billion for the fiscal year ending January 1, 2021, emphasizing its role in tackling complex challenges across various sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
conferences
-
News
Rhea-AI Summary

Leidos (NYSE: LDOS) has secured a prime contract worth up to $110 million from the FBI to provide fitness for duty medical exam services. Awarded by the FBI's Human Resources Division, the contract includes a base period of 12 months with four potential 12-month extensions. QTC Medical Services, a subsidiary of Leidos, will offer various occupational health services, building on its existing relationship with the FBI since 2012. This contract expands QTC's role in supporting FBI personnel with comprehensive medical examinations and related services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
none
Rhea-AI Summary

Leidos (NYSE: LDOS), a leader in technology and science solutions, will participate in the Bernstein 37th Annual Strategic Decisions Conference on June 2, 2021, at 1:30 p.m. ET. CEO Roger Krone will engage in a Q&A session during the event. The conference will be accessible via a live audio webcast on the Leidos Investor Relations website. Following the event, a replay will be available for one year. Leidos, headquartered in Reston, VA, reported annual revenues of approximately $12.30 billion in the fiscal year ended January 1, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
conferences
-
Rhea-AI Summary

Leidos Holdings, Inc. (NYSE: LDOS) has successfully completed the acquisition of Gibbs & Cox, Inc. for approximately $380 million in cash. The acquisition allows Gibbs & Cox to operate as a wholly-owned subsidiary under Leidos' maritime systems division, enhancing Leidos' capability to provide engineering solutions to the US Navy and foreign navies. The move is expected to strengthen Leidos' position in the growing maritime undersea, autonomous, and cybersecurity sectors, leveraging Gibbs & Cox's expertise in naval architecture and design.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
-
Rhea-AI Summary

Leidos Holdings, Inc. (NYSE: LDOS) has successfully acquired Gibbs & Cox, Inc. for approximately $380 million in cash. This acquisition enhances Leidos' maritime capabilities, allowing it to offer broader engineering solutions to the US Navy and international navies. Gibbs & Cox will operate as a wholly owned subsidiary and is known as the largest independent ship design firm in the U.S., specializing in naval architecture and marine engineering. The merger signifies Leidos' commitment to innovation and growth in the maritime sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
Rhea-AI Summary

Leidos (NYSE:LDOS) was awarded a spot on the Defense Intelligence Agency's (DIA) Solutions for the Information Technology Enterprise III (SITE III) contract, valued at $12.6 billion. This 10-year multiple-award contract allows Leidos to support the DIA and compete for related task orders, addressing evolving IT requirements critical for U.S. security. Leidos will deliver comprehensive IT support services and contribute to national security missions globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
none

FAQ

What is the current stock price of Leidos Holdings (LDOS)?

The current stock price of Leidos Holdings (LDOS) is $178.44 as of August 14, 2025.

What is the market cap of Leidos Holdings (LDOS)?

The market cap of Leidos Holdings (LDOS) is approximately 22.8B.
Leidos Holdings

NYSE:LDOS

LDOS Rankings

LDOS Stock Data

22.84B
127.30M
0.67%
80.76%
2.39%
Information Technology Services
Services-computer Integrated Systems Design
Link
United States
RESTON